Literature DB >> 24176423

Clinical neurogenetics: neuropathic lysosomal storage disorders.

Gregory M Pastores1, Gustavo H B Maegawa.   

Abstract

The lysosomal storage disorders are a clinically heterogeneous group of inborn errors of metabolism, associated with the accumulation of incompletely degraded macromolecules within several cellular sites. Affected individuals present with a broad range of clinical problems, including hepatosplenomegaly and skeletal dysplasia. Onset of symptoms may range from birth to adulthood. Most are associated with neurologic features. Later-onset forms are often misdiagnosed as symptoms, which might include psychiatric manifestations, are slowly progressive, and may precede other neurologic or systemic features. Symptomatic care, which remains the mainstay for most subtypes, can lead to significant improvement in quality of life.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Leukodystrophy; Lysosomal storage disorders; Myopathy; Stroke

Mesh:

Year:  2013        PMID: 24176423      PMCID: PMC3988112          DOI: 10.1016/j.ncl.2013.04.007

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  62 in total

Review 1.  Management of neuronopathic Gaucher disease: a European consensus.

Authors:  A Vellodi; B Bembi; T B de Villemeur; T Collin-Histed; A Erikson; E Mengel; A Rolfs; A Tylki-Szymanska
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

2.  Autophagy suppresses interleukin-1β (IL-1β) signaling by activation of p62 degradation via lysosomal and proteasomal pathways.

Authors:  Jongdae Lee; Hye Ri Kim; Christine Quinley; Joanna Kim; Jose Gonzalez-Navajas; Ramnik Xavier; Eyal Raz
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

Review 3.  Lysosomal disorders.

Authors:  J E Wraith
Journal:  Semin Neonatol       Date:  2002-02

4.  Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion.

Authors:  Patricia Boya; Karine Andreau; Delphine Poncet; Naoufal Zamzami; Jean-Luc Perfettini; Didier Metivier; David M Ojcius; Marja Jäättelä; Guido Kroemer
Journal:  J Exp Med       Date:  2003-05-19       Impact factor: 14.307

5.  Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats.

Authors:  Dyane Auclair; John Finnie; Steven U Walkley; Joleen White; Timothy Nielsen; Maria Fuller; Alphonsus Cheng; Charles A O'Neill; John J Hopwood
Journal:  Pediatr Res       Date:  2012-01       Impact factor: 3.756

6.  Immune modulation in Pompe disease treated with enzyme replacement therapy.

Authors:  Suhrad G Banugaria; Trusha T Patel; Priya S Kishnani
Journal:  Expert Rev Clin Immunol       Date:  2012-08       Impact factor: 4.473

7.  Cardiac magnetic resonance imaging in Danon disease.

Authors:  Gaetano Nucifora; Daniela Miani; Gianluca Piccoli; Alessandro Proclemer
Journal:  Cardiology       Date:  2012-02-29       Impact factor: 1.869

8.  The impact of antibodies in late-onset Pompe disease: a case series and literature review.

Authors:  Trusha T Patel; Suhrad G Banugaria; Laura E Case; Stephan Wenninger; Benedikt Schoser; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2012-05-09       Impact factor: 4.797

9.  Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management.

Authors:  Katherine Kirkpatrick; James Ellwood; Robert W M Walker
Journal:  Paediatr Anaesth       Date:  2012-06-07       Impact factor: 2.556

10.  Psychosine induces the dephosphorylation of neurofilaments by deregulation of PP1 and PP2A phosphatases.

Authors:  Ludovico Cantuti-Castelvetri; Hongling Zhu; Maria I Givogri; Robstein L Chidavaenzi; Aurora Lopez-Rosas; Ernesto R Bongarzone
Journal:  Neurobiol Dis       Date:  2012-02-04       Impact factor: 5.996

View more
  11 in total

Review 1.  Lysosomal Leukodystrophies Lysosomal Storage Diseases Associated With White Matter Abnormalities.

Authors:  Gustavo H B Maegawa
Journal:  J Child Neurol       Date:  2019-02-13       Impact factor: 1.987

2.  Liver-Directed Human Amniotic Epithelial Cell Transplantation Improves Systemic Disease Phenotype in Hurler Syndrome Mouse Model.

Authors:  Natalie S Rodriguez; Lisa Yanuaria; Kevin Murphy R Parducho; Irving M Garcia; Bino A Varghese; Brendan H Grubbs; Toshio Miki
Journal:  Stem Cells Transl Med       Date:  2017-06-06       Impact factor: 6.940

Review 3.  Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases.

Authors:  James C Dodge
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

4.  Reduced Intracranial Volume in Fabry Disease: Evidence of Abnormal Neurodevelopment?

Authors:  Giuseppe Pontillo; Sirio Cocozza; Arturo Brunetti; Vincenzo Brescia Morra; Eleonora Riccio; Camilla Russo; Francesco Saccà; Enrico Tedeschi; Antonio Pisani; Mario Quarantelli
Journal:  Front Neurol       Date:  2018-08-17       Impact factor: 4.003

5.  Neuronal Soma-Derived Degradative Lysosomes Are Continuously Delivered to Distal Axons to Maintain Local Degradation Capacity.

Authors:  Tamar Farfel-Becker; Joseph C Roney; Xiu-Tang Cheng; Sunan Li; Sean R Cuddy; Zu-Hang Sheng
Journal:  Cell Rep       Date:  2019-07-02       Impact factor: 9.423

6.  Bi-functional IgG-lysosomal enzyme fusion proteins for brain drug delivery.

Authors:  Ruben J Boado; Jeff Zhiqiang Lu; Eric Ka-Wai Hui; Huilan Lin; William M Pardridge
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

Review 7.  CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges.

Authors:  Mariola J Edelmann; Gustavo H B Maegawa
Journal:  Front Mol Biosci       Date:  2020-11-12

Review 8.  A Compendium of Information on the Lysosome.

Authors:  Nadia Bouhamdani; Dominique Comeau; Sandra Turcotte
Journal:  Front Cell Dev Biol       Date:  2021-12-15

9.  Genotype by environment interactions for chronic wasting disease in farmed US white-tailed deer.

Authors:  Christopher M Seabury; Mitchell A Lockwood; Tracy A Nichols
Journal:  G3 (Bethesda)       Date:  2022-07-06       Impact factor: 3.542

10.  Glucosylceramide synthase inhibition reduces ganglioside GM3 accumulation, alleviates amyloid neuropathology, and stabilizes remote contextual memory in a mouse model of Alzheimer's disease.

Authors:  James C Dodge; Thomas J Tamsett; Christopher M Treleaven; Tatyana V Taksir; Peter Piepenhagen; S Pablo Sardi; Seng H Cheng; Lamya S Shihabuddin
Journal:  Alzheimers Res Ther       Date:  2022-02-01       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.